Henan Taloph Pharmaceutical Stock Co.,Ltd

SHSE:600222 Stock Report

Market Cap: CN¥2.9b

Henan Taloph Pharmaceutical StockLtd Balance Sheet Health

Financial Health criteria checks 4/6

Henan Taloph Pharmaceutical StockLtd has a total shareholder equity of CN¥1.6B and total debt of CN¥911.8M, which brings its debt-to-equity ratio to 56.3%. Its total assets and total liabilities are CN¥3.7B and CN¥2.1B respectively. Henan Taloph Pharmaceutical StockLtd's EBIT is CN¥106.5M making its interest coverage ratio 2. It has cash and short-term investments of CN¥397.8M.

Key information

56.3%

Debt to equity ratio

CN¥911.84m

Debt

Interest coverage ratio2x
CashCN¥397.75m
EquityCN¥1.62b
Total liabilitiesCN¥2.10b
Total assetsCN¥3.72b

Recent financial health updates

No updates

Recent updates

The Market Doesn't Like What It Sees From Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) Revenues Yet

Sep 27
The Market Doesn't Like What It Sees From Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) Revenues Yet

Henan Taloph Pharmaceutical StockLtd (SHSE:600222) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 06
Henan Taloph Pharmaceutical StockLtd (SHSE:600222) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Henan Taloph Pharmaceutical Stock Co.,Ltd (SHSE:600222) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Mar 08
Henan Taloph Pharmaceutical Stock Co.,Ltd (SHSE:600222) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Financial Position Analysis

Short Term Liabilities: 600222's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥2.0B).

Long Term Liabilities: 600222's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥102.7M).


Debt to Equity History and Analysis

Debt Level: 600222's net debt to equity ratio (31.7%) is considered satisfactory.

Reducing Debt: 600222's debt to equity ratio has reduced from 83.7% to 56.3% over the past 5 years.

Debt Coverage: 600222's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 600222's interest payments on its debt are not well covered by EBIT (2x coverage).


Balance Sheet


Discover healthy companies